Interleukin-1 receptor antagonist autoantibodies in Still’s disease: Mechanistic insights and laboratory testing

doi:10.5662/wjm.v16.i2.114269

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

(37)

(39)

(0)

(51)

(758)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Methodol. Jun 20, 2026; 16(2): 114269
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.114269

Full Size Figure Download Figure

Figure 2 Approaches for the detection and characterization of anti-interleukin-1 receptor accessory autoantibodies. SEAP: Secretion of embryonic alkaline phosphatase; rec hIL-1RA: Recombinant human interleukin-1 receptor antagonist; IL-1RAP: Interleukin-1 receptor accessory protein; IL-1R1: Interleukin-1 receptor type 1; OD: Optical density; HEK: Human embryonic kidney; Anti-FLAG mAb: Anti-FLAG monoclonal antibody; HRP: Horseradish peroxidase; ELISA: Enzyme-linked immunosorbent.

Citation: Bouayad A. Interleukin-1 receptor antagonist autoantibodies in Still’s disease: Mechanistic insights and laboratory testing. World J Methodol 2026; 16(2): 114269
URL: https://www.wjgnet.com/2222-0682/full/v16/i2/114269.htm
DOI: https://dx.doi.org/10.5662/wjm.v16.i2.114269

Bouayad A. Interleukin-1 receptor antagonist autoantibodies in Still’s disease: Mechanistic insights and laboratory testing. World J Methodol 2026; 16(2): 114269 [PMID: 42058797 DOI: 10.5662/wjm.v16.i2.114269]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.